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ABSTRACT 
Sulforaphane is a redox-active natural product present in cruciferous vegetables like broccoli. 
Broccoli sprout-derived products are promising agents for the prevention of oxidative stress-
related diseases, but some have long been suspected of thyroidal toxicity. Recent findings 
also raise the possibility that long-term exposure to sulforaphane, or to other natural 
substances or drugs that modulate the activity of the transcription factor Nrf2 (NFE2-related 
factor 2) may lead to thyroid dysfunction or thyroid autoimmune disease, questioning the 
safety of trials with sulforaphane-containing products. Previous studies addressing possible 
effects of sulforaphane-related compounds from natural product extracts on the thyroid were 
quite short and/or inconsistent. To investigate whether long-term exposure to a beverage 
enriched with sulforaphane and its precursor glucoraphanin may affect thyroid function, we 
analyzed biochemical measures of thyroid function and thyroid autoimmunity in 45 female 
participants in a randomized clinical trial at baseline and after 84 days of beverage 
administration. Serum levels of thyroid-stimulating hormone, free thyroxine and 
thyroglobulin were not affected by the treatment, and neither was the thyroid autoimmunity 
status of participants. These results provide evidence in favor of the safety of 
chemoprevention strategies that target the activation of Nrf2 to protect against environmental 
exposures and other oxidative stress-related pathologies. 
 
KEYWORDS 
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INTRODUCTION 
 
Sulforaphane (1-Isothiocyanato-4-(methylsulfinyl)butane) is a redox-active natural substance 
that belongs to the isothiocyanate group and is present in foods and specifically in cruciferous 
vegetables like broccoli sprouts. These vegetables contain various glucosinolates including 
glucoraphanin (4-Methylsulfinylbutyl glucosinolate), the precursor of sulforaphane, which is 
converted to active sulforaphane via the catalytic activity of the plant enzyme myrosinase 
(Fahey et al., 2012). One of the best-characterized molecular targets of sulforaphane is the 
redox-sensitive transcription factor Nrf2 (NFE2-related factor 2). The activation of Nrf2 
signaling by sulforaphane promotes binding  of the transcription factor to DNA sequences 
called antioxidant response elements (AREs), with subsequent transcriptional upregulation of 
a battery of genes that function in antioxidant defense, cellular detoxification and other cell-
protective mechanisms (Yamamoto et al., 2018). Broccoli sprout preparations are thus 
considered as promising natural products for the prevention of diseases related to oxidative 
stress, whereby the activation of proteostatic pathways by the administered compound(s) may 
prevent the onset or modify the natural course of disease pathogenesis (Yang et al., 2016). 
For example, a randomized clinical trial in China has shown that broccoli sprout beverage 
promotes the rapid and sustainable detoxification of airborne pollutants (Egner et al., 2014). 
Other trials with sulforaphane-rich broccoli sprout extracts demonstrated reductions of fasting 
blood glucose and glycated hemoglobin in obese patients with deregulated type 2 diabetes 
mellitus (Axelsson et al., 2017) as well as clinical improvement of symptoms related to 
autism spectrum disorder (Singh et al., 2014). 
 
We have recently found that in cultured thyroid follicular cells, sulforaphane directly up-
regulates the mRNA level and the protein abundance of thyroglobulin (TG), the precursor of 
thyroid hormones (Ziros et al., 2018). It does so by activating Nrf2, which in turn binds to 
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two AREs in a conserved upstream enhancer of the gene encoding TG (Ziros et al., 2018). 
Moreover, it is known that when Nrf2-disrupted mice are bred into autoimmunity-permissive 
genetic backgrounds, they tend to develop an age-related systemic autoimmune syndrome, 
although it has not been reported whether the thyroid grand is also affected (Li et al., 2004; 
Ma et al., 2006; Yoh et al., 2001). These findings raise the possibility that long-term exposure 
to sulforaphane, or to other natural substances or drugs that modulate Nrf2 activity, may lead 
to thyroid dysfunction and cause hypothyroidism, hyperthyroidism or thyroid autoimmune 
disease, bringing into question the safety of interventions with sulforaphane or sulforaphane-
containing products. 
A small number of studies in humans and animals, reviewed by Felker et al. (Felker et al., 
2016) and Latte et al. (Latte et al., 2011), have raised concerns about the possible effects of 
natural product extracts that contain glucosinolates and isothiocyanates on thyroid gland 
function. This is mostly based on the potential competitive inhibition of the sodium/iodide 
symporter by the thiocyanate ion (Tonacchera et al., 2004), which could lead to impaired 
iodide import and thus to reduced synthesis of thyroid hormones, resulting in 
hypothyroidism. However a decades-old study that addressed the effect of the addition of 8 
mg thiocyanate in milk consumed daily for 12 weeks by human healthy volunteers showed no 
effect on thyroid hormone levels, with all subjects remaining euthyroid (Dahlberg et al., 
1984). Another metabolite of glucosinolates with potential detrimental effects on thyroid 
function is goitrin (5-ethenyl-1,3-oxazolidine-2-thione). Goitrin synthesis from progoitrin, 
which can be detected in broccoli in trace amounts (Tian et al., 2005), is actually facilitated 
by myrosinase, the same enzyme that converts glucoraphanin into sulforaphane. Even though 
the circulating levels of goitrin after consumption of broccoli have not been directly 
measured in humans,  it is known that administration of goitrin to humans can impair iodine 
uptake by the thyroid An old preliminary clinical trial on the effect of cooked Brussels 
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sprouts administered to humans for 4 weeks showed no effects on thyroid function tests 
(McMillan et al., 1986); the authors speculated that this lack of activity of cooked Brussels 
sprouts is due to inactivation during cooking of myrosinase, the glucosinolate-metabolizing 
enzyme. This biochemical effect (later verified by other studies) is the rationale why the field 
trial in China within which the present study is nested used a sulforaphane-rich broccoli 
sprout beverage, in which myrosinase was used to catalyze the conversion of glucoraphanin 
into active sulforaphane (Egner et al., 2014). In addition, a myrosinase-like ß-thioglucosidase 
in the gut microflora also hydrolyzes glucoraphanin in the beverage to sulforaphane. A small 
phase I human clinical trial on the safety, tolerance, and metabolism of broccoli sprout 
glucosinolates and isothiocyanates (Shapiro et al., 2006) found no significant or consistent 
subjective or objective thyroidal toxicities; however, the study was very short (only 1 week) 
and small (only 3 subjects per group).  
 
Regarding animal models, in decades-old studies the effect of goitrin on the thyroid has been 
investigated using rats (Faiman et al., 1967)  and chicken (Akiba and Matsumoto, 1976); 
goitrin administration was shown to inhibit iodide uptake and to increase the weight of 
thyroid gland, causing goiter, hence the name of the substance. In another, more clinically 
relevant study, rats were administered over 4 weeks test diets with 15% or 30% of the dry 
food matter as uncooked or cooked Brussels sprouts and control diets with or without 0.2% 
potassium thiocyanate (a known thyroid function inhibitor) for comparison; it also 
administered diets with 0, 2.5, 5, 10 and 20% of the cooked vegetable, as well as diets with 0 
and 20% of the cooked vegetable with extra iodine (de Groot et al., 1991). While thyroid-
stimulating hormone (TSH, the most sensitive indicator of thyroid function) was not 
increased by feeding the vegetable, morphological activation of the thyroid (assessed by 
histology) was increased with 10% or more of the cooked vegetable (de Groot et al., 1991). 
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These results suggest that the type and degree of preparation during cooking can affect the 
content of thyroid-active substances in diverse ways; hence, results may vary depending on 
the specific formulation and preparation method employed. 
 
In summary, published studies on the thyroidal safety of plant-based compounds that activate 
Nrf2 are few in number, short in duration and/or inconsistent regarding the preparation of the 
plant extract and its possible effects on the thyroid gland. Therefore, to investigate whether 
long-term exposure to an orally administered sulforaphane-rich broccoli sprout beverage has 
an impact on thyroid function, we analyzed biochemical measures of thyroid function and 
thyroid autoimmunity in a subset of the participants in the aforementioned broccoli sprout 
clinical trial (Egner et al., 2014).  
 
 
 
MATERIALS AND METHODS 
Study design 
The present work is a retrospective analysis of a subset of serum samples collected during a 
clinical trial that was conducted from mid-October 2011 to early January 2012 in the rural 
farming community of He-He Township, Qidong, Jiangsu Province, China (NCT number 
01437501 in ClinicalTrials.gov). The structure of this clinical trial has been previously 
described in detail (Egner et al., 2014). Briefly, adults in good general health were 
randomized in a placebo-controlled trial designed to evaluate the pharmacokinetics and 
pharmacodynamics of a beverage containing 40 µmol sulforaphane and 600 µmol of its 
biogenic precursor glucoraphanin, both coming from 3-day old broccoli sprouts. Written 
informed consent was obtained from all participants; the Institutional Review Boards of the 
Johns Hopkins Bloomberg School of Public Health, the Qidong Liver Cancer Institute and 
the University of Pittsburgh approved the protocols for the trial and for the biochemical 
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analyses, respectively. 1205 individuals aged 21-65 years old were screened at local clinics 
by methods used in previous studies in the area (Kensler et al., 2012) and 539 were deemed 
eligible for the study. The initial 300 were randomized using a fix randomization scheme 
with a block size of 10; 79% were women and 21% men. Finally, 130 individuals completed 
the trial receiving placebo beverage and 137 receiving the broccoli sprout beverage for 84 
consecutive days (12 weeks). Serum samples from a subset (5 randomization blocks) of 
participants were selected for the present study; only samples (n=45) from females were 
analyzed. Their baseline characteristics are shown in Table 1. 
 
Preparation and quality control of broccoli sprout and placebo beverages 
Broccoli sprouts were grown from specially selected BroccoSprouts seeds (cv. DM1999B) 
with technology licensed from Johns Hopkins University. The preparation of the broccoli 
sprouts extracts has been previously described in detail (Egner et al., 2014). Briefly, after 3 
days of sprout growth, sprouts were allowed to boil for 30 minutes in deionized water. This 
aqueous extract contained about 5 mM glucoraphanin, the sulforaphane precursor, and was 
lyophilized to a glucoraphanin-rich powder that contained 329 µmol/g glucoraphanin as 
assessed by HPLC (Wade et al., 2007). The sulforaphane-rich powder was prepared by 
treating the aqueous broccoli sprout extract with myrosinase, an enzyme released from 
daikon (Raphanus sativus) sprouts, at 37°C for 4 hours to hydrolyze the glucosinolates to 
isothiocyanates. Total isothiocyanates levels were quantified by cyclocondensation analysis 
(Ye et al., 2002) and the sulforaphane levels were assessed by direct HPLC (Tang et al., 
2006). This hydrolyzed aqueous extract was lyophilized to the sulforaphane-rich powder that 
contained 202 µmol/g sulforaphane, representing 91% of the total isothiocyanate content in 
the powder. To prepare the daily dose of broccoli sprout extract or placebo for the study 
participants, 360 g glucoraphanin- and 24 g sulforaphane-rich powder were dissolved in 
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sterile water. Then, a mixture of 47:47:6 water: pineapple juice: lime juice was prepared, and 
100 ml were distributed to each participant; the individual daily dose was 600 µmol of 
glucoraphanin and 40 µmol of sulforaphane (Egner et al., 2014). Placebo contained the same 
liquid components plus 1% molasses for color masking purposes. The placebo beverage 
contained no measurable glucoraphanin or sulforaphane and, unlike the broccoli sprout-
derived beverage, showed negligible Nrf2 inducer activity in in vitro assays.  
 
Serum analyses 
Blood samples from day 0 and day 84 (last day) of the study were collected from all 
participants. In a subset of 45 female participants, serum TSH, free thyroxine (fT4), 
thyroglobulin (TG), anti-TG and anti-thyroid peroxidase (anti-TPO) antibodies were 
measured at the UPMC Presbyterian Automated Testing Laboratory and Immunoserology 
Laboratory (Pittsburgh, PA) using aliquoted serum samples that had been stored frozen (-
80°C) since collection. TSH was measured using the immunoenzymatic Access TSH (3rd IS) 
assay (Beckman Coulter, Brea, CA) in a DXI 800 analyzer (Beckman Coulter); TSH 
reference range: 0.45-5.33 mIU/L. fT4 was measured using the fT4 ADVIA Centaur 
immunoassay (Siemens Healthcare Diagnostics) in an ADVIA Centaur analyzer (Siemens 
Healthcare Diagnostics, Tarrytown, NY); fT4 reference range: 0.89-1.76 ng/dl. TG was 
measured using the immunoenzymatic Access Thyroglobulin assay (Beckman Coulter) in a 
DXI 800 analyzer. Anti-TG and anti-TPO levels were measured using solid-phase, enzyme-
labeled, chemiluminescent sequential immunometric assays (Siemens Healthcare 
Diagnostics) in an Immulite 2000XPi analyzer (Siemens Healthcare Diagnostics); reference 
ranges: <20 IU/mL for anti-TG antibodies and <10 IU/ml for anti-TPO antibodies. Both the 
laboratory and the specific assays are certified for clinical use. 
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Statistical analyses 
G*power software (Faul et al., 2009)  was used to calculate the sample size needed for serum 
measurements of TSH, fT4 and TG. For two-way ANOVA repeated measures, to detect a 
medium effect size (f=0.25) with a power of 0.85 and α error set at 0.05, at least 19 samples 
per group are needed. As most of the participants in the clinical trial were women, we 
selected for analysis sera from a randomly pre-scrambled bloc of 50 study participants that 
comprised 19 women on placebo treatment and 26 women on broccoli sprout extract 
treatment with a mean age of about 48 and 41 years old respectively (as well as 5 men, not 
analyzed, who by chance had all received placebo). Groups were compared for characteristics 
at baseline (day 0) by Mann-Whitney test or chi-square test, as appropriate. To assess for 
effects of the broccoli sprout extract beverage, TSH, fT4 and TG levels were compared 
between the groups by two-way ANOVA with repeated measures using GraphPad Prism 7.00 
(GraphPad Software, La Jolla, CA). Regarding thyroid autoimmunity status, the percentages 
of participants that were seropositive for either anti-TG or anti-TPO antibodies (or both) or 
seronegative for both anti-TG and anti-TPO antibodies were compared by chi-square test at 
days 0 and 84. Statistical significance was set at p<0.05. 
 
 
RESULTS 
Thyroid function  
When comparing baseline characteristics between the placebo and treatment groups, there 
was a small but statistically significant difference in TSH levels (Table 1, comparison by 
Mann-Whitney test); nevertheless, mean values were within the reference range for both 
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groups. Importantly, when the whole dataset (baseline and end-of-treatment) was analyzed by 
repeated measures two-way ANOVA, neither time nor treatment group allocation nor their 
interaction had a significant effect on TSH levels (p=0.39, p=0.23 and p=0.70, respectively) 
(Figure 1A, 1B). Similarly, neither time nor treatment group allocation nor their interaction 
had a significant effect on fT4 levels (p=0.12, p=0.29 and p=0.41, respectively), (Figure 1C, 
1D). Moreover, the percentage of patients with subclinical hypothyroidism (elevated TSH 
with normal fT4) was not different between the two groups either before or after treatment 
(p=0.99 and p=0.2807, respectively) (Figure 2A). Taken together, these results indicate that 
thyroid function overall is unaffected by consuming the broccoli sprout extract beverage. 
 
Thyroglobulin 
Because Nrf2 has been shown to control the expression of the TG gene, thyroglobulin levels 
were measured to assess for a possible impact of the broccoli sprout beverage. Given that 
anti-TG antibodies can interfere in the TG measurement assay, only subjects with anti-TG 
antibody titers within the reference range were retained in these analyses. Despite a near-
significant difference among the two treatment allocation groups (p=0.06), neither time nor 
its interaction with treatment group allocation had a significant effect on TG levels (p=0.72 
and p=0.67, respectively) (Fig. 1E, 1F). These results indicate that serum TG levels are 
unaffected by the broccoli sprout extract beverage. 
 
Thyroid autoimmunity 
The percentage of participants that were seropositive for either anti-TG or anti-TPO 
antibodies (or both) was not different between the placebo group and the broccoli sprout 
extract beverage group either before treatment (57.9% in placebo group vs. 42.3 % in 
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treatment group, p=0.37) or after treatment (57.9 % in placebo group vs. 34.6 % in treatment 
group, p=0.14) (Figure 2B). 
 
DISCUSSION 
In the present study, thyroid function tests and measures of thyroid autoimmunity among 
participants in a randomized clinical trial of a broccoli sprout extract beverage versus placebo 
for 84 days showed no evidence for adverse effects of this treatment on the thyroid gland. 
Because this was a retrospective study nested within the original clinical trial, there are 
certain limitations that should be acknowledged. First, thyroidal parameters were assessed at 
only two time points. Since intermediate points were not included, temporary changes cannot 
be ruled out, but since measures were overall unchanged at 84 days, temporary changes 
would not be expected to have clinical relevance. Effects at longer durations of treatment can 
also not be excluded, but appear unlikely in view of the present results. Secondly, the 
participants were not selected for normal thyroid function at baseline, but were a randomly 
picked subset among the participants in the trial. The broccoli extract treatment and placebo 
groups analyzed here had a statistically significant difference in the age of participants (Table 
1). It is known that serum TSH levels increase with age, likely as part of a physiological 
adaptation to aging. From a clinical perspective, the mean difference in age between the 
groups being small (6.84 years), it is unlikely to impact the results. In addition, in the two-
way ANOVA repeated measures design employed to analyze the data, each participant serves 
as their own control. Lastly, the reference ranges employed are not specific for the Chinese 
population. However, the fact that no effects of the treatment were observed on TSH, fT4 and 
TG levels is independent of the absolute values of the respective reference ranges. 
 
Notwithstanding these limitations, the data do provide strong evidence in favor of the safety 
of the specific regimen as far as the thyroid gland is concerned. One possible explanation is 
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that, under the specific dosing regimen, the thyroid gland may not be exposed to substantial 
concentrations of sulforaphane; this is clearly not the case for other tissues, because a 
rigorous, sustained effect on air pollution biomarkers was observed in the same study (Egner 
et al., 2014). Given that the study analyzed the main biomarkers of thyroid function that can 
be measured non-invasively, there is no plausible way to confirm or refute this hypothesis 
using the materials available. Furthermore, in view of the data, the prospective use of 
invasive methods to directly address the question (e.g., measurement of sulforaphane or of 
mRNA levels of Nrf2 target genes in material obtained from thyroid fine-needle aspiration 
biopsy) is not justified either. If sulforaphane does reach the thyroid and activate Nrf2 in 
thyroid follicular cells, then the alternative hypothesis would be that the thyroid has 
mechanisms that can prevent such activation of Nrf2 from impacting the hormone synthesis 
machinery and ultimately the gland’s function. Auto-regulatory mechanisms are believed to 
exist in thyroid follicular cells that can compensate for reduced Nrf2 activity (Ziros et al., 
2018), so it is conceivable that such mechanisms may also protect against increased Nrf2 
activity, at least to a certain extent. Interestingly, chronic, potent activation of Nrf2 signaling 
due to inherited loss-of-function mutations in the KEAP1 gene that encodes the main 
inhibitor of Nrf2 have been associated with goiter in two unrelated Japanese families 
(Nishihara et al., 2016; Teshiba et al., 2013). Due to the retrospective nature of the present 
study, whose parent trial did not evaluate thyroid volume either by palpation or ultrasound, it 
is not possible to address this issue. Thus, these questions warrant further investigation in 
animal model studies. From a clinical perspective, the results of such studies could also help 
to address the question whether monitoring thyroid function is systematically warranted in 
clinical trials of Nrf2-activating compounds, or whether it can be generally assumed that all 
such compounds are safe for the thyroid gland (save for potential Nrf2-independent 
mechanisms). In the meantime, it may be prudent to evaluate the thyroidal safety of plant-
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based food supplements on a case-by-case basis, because the effects may vary depending on 
the plant used and the preparation of the extract, and therefore it may not be safe to draw 
conclusions from previous studies using different approaches.  
 
In conclusion, the present study showed that daily ingestion of a broccoli sprout extract 
beverage over 84 days had no deleterious effect on thyroid function tests or measures of 
thyroid autoimmunity, providing evidence in favor of the safety of controlled 
chemoprevention strategies that target the activation of Nrf2 to protect against environmental 
exposures and other oxidative stress- and inflammation-related pathologies. 
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TABLE 1 
 
group placebo  broccoli sprout p-value 
number 19 26 N/A 
female (n, %) 19 (100%) 26 (100%) N/A 
age (mean ±S.E.M.) 48.1 ± 1.6 41.3 ±1.8 <0.01 
TSH (mean ±S.E.M.) 4.58 ± 0.47 3.8 ± 0.6 0.041 
fT4 (mean ±S.E.M.) 1.51 ± 0.05 1.59 ± 0.04 0.15 
TG (mean ±S.E.M.) 10.81 ± 1.71 7.47 ± 0.85 0.15 
subclinical hypothyroidism (n, %) 5 (26%) 6 (23%) 0.99 
anti-TG and/or anti-TPO 
seropositivity (n, %) 
11 (58%) 11 (42%) 0.37 
 
Characteristics of participants at baseline. N/A, not applicable; n, number; S.E.M., standard 
error of the mean; seropositivity, titer of anti-TG antibodies or anti-TPO antibodies (or both) 
above the respective reference range. 
 
 
 
 
FIGURE LEGENDS 
 
Figure 1: Individual and mean (±S.E.M.) values of TSH (A and B), fT4 (C and D) and TG (E 
and F), respectively, at baseline and after 84 days of broccoli sprout beverage or placebo 
ingestion. The upper and lower limits of the reference range for TSH (0.45-5.33 mIU/L) and 
fT4 (0.89-1.76 ng/dl) are indicated by horizontal lines in panels A and C, respectively. 
 
Figure 2: (A) Number of subjects with subclinical hypothyroidism at baseline and after 84 
days of broccoli sprout beverage or placebo ingestion. (B) Number of subjects positive for 
anti-TPO and/or anti-TG antibodies at baseline and after 84 days of broccoli sprout beverage 
or placebo ingestion. 
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1 
 
HIGHLIGHTS  
• A broccoli sprout beverage was administered to healthy volunteers as a source of 
sulforaphane to activate Nrf2 signaling. 
• Daily consumption of the sulforaphane-rich beverage for 12 weeks did not affect the 
serum levels of fT4, TSH and TG. 
• The thyroid autoimmunity status of participants after 12 weeks on the broccoli sprout 
beverage was also unaffected. 
• Long-term ingestion of a sulforaphane-rich broccoli sprout beverage is safe for the 
thyroid gland. 
• Natural products activating Nrf2 should be individually evaluated for effects on 
thyroid hormonal and autoimmune status. 
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